Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine for anthracycline-induced cardiotoxicity
NCT04030546Phase 3Unknown
- Sponsor
- Vilnius University
- Start
- Jun 2019
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ivabradine in anthracycline-induced cardiotoxicity, sponsored by Vilnius University. Status: unknown.
02
Drugs
ivabradine
03
Conditions
anthracycline-induced cardiotoxicity
Beyond the preview
Go deeper on NCT04030546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04030546.